These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 2463075

  • 1. Detection of membrane-bound alpha-fetoprotein in human hepatoma cell lines by monoclonal antibody 19F12.
    Hosokawa S, Muramatsu M, Nagaike K.
    Cancer Res; 1989 Jan 15; 49(2):361-6. PubMed ID: 2463075
    [Abstract] [Full Text] [Related]

  • 2. Selective cytotoxic effects of immunotoxin--monoclonal anti-AFP-abrin-A chain conjugate on several human hepatoma cell lines.
    Chow LP, Chang KH, Lin JY.
    Biochem Int; 1990 Oct 15; 22(1):95-102. PubMed ID: 1704234
    [Abstract] [Full Text] [Related]

  • 3. A new tumor-associated antigen useful for serodiagnosis of hepatocellular carcinoma, defined by monoclonal antibody KM-2.
    Kumagai Y, Chiba J, Sata T, Ohtaki S, Mitamura K.
    Cancer Res; 1992 Sep 15; 52(18):4987-94. PubMed ID: 1381274
    [Abstract] [Full Text] [Related]

  • 4. Effects of ricin A chain conjugates of monoclonal antibodies to human alpha-fetoprotein and placental alkaline phosphatase on antigen-producing tumor cells in culture.
    Tsukazaki K, Hayman EG, Ruoslahti E.
    Cancer Res; 1985 Apr 15; 45(4):1834-8. PubMed ID: 2579736
    [Abstract] [Full Text] [Related]

  • 5. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
    Hiraiwa N, Tsuyuoka K, Li YT, Tanaka M, Seno T, Okubo Y, Fukuda Y, Imura H, Kannagi R.
    Cancer Res; 1990 Sep 01; 50(17):5497-503. PubMed ID: 2167157
    [Abstract] [Full Text] [Related]

  • 6. [Effect of alpha-fetoprotein on the growth of human hepatoma cells in vitro].
    Wang XW, Xie H.
    Shi Yan Sheng Wu Xue Bao; 1999 Mar 01; 32(1):15-22. PubMed ID: 12548790
    [Abstract] [Full Text] [Related]

  • 7. [Action of monoclonal antibody against a hepatocellular carcinoma cell line (PLC/PRF/5)].
    Shao RP.
    Zhonghua Zhong Liu Za Zhi; 1986 Jul 01; 8(4):259-61. PubMed ID: 3019621
    [Abstract] [Full Text] [Related]

  • 8. Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
    Masuda K, Takahashi K, Nagata S, Hirano K, Takagishi Y.
    J Drug Target; 1994 Jul 01; 2(4):323-31. PubMed ID: 7532086
    [Abstract] [Full Text] [Related]

  • 9. alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis.
    Kawai HF, Kaneko S, Honda M, Shirota Y, Kobayashi K.
    Hepatology; 2001 Mar 01; 33(3):676-91. PubMed ID: 11230749
    [Abstract] [Full Text] [Related]

  • 10. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.
    Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637
    [Abstract] [Full Text] [Related]

  • 11. [Cytotoxic effect of anticancer drug combined with anti-AFP antibody on human hepatoma cell in vitro].
    Kukita K.
    Hokkaido Igaku Zasshi; 1990 May 01; 65(3):254-65. PubMed ID: 1696238
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies directed to a disulfated glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), associated with human hepatocellular carcinoma.
    Hiraiwa N, Iida N, Ishizuka I, Itai S, Shigeta K, Kannagi R, Fukuda Y, Imura H.
    Cancer Res; 1988 Dec 01; 48(23):6769-74. PubMed ID: 2846160
    [Abstract] [Full Text] [Related]

  • 13. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K.
    Gene Ther; 1999 Apr 01; 6(4):465-70. PubMed ID: 10476206
    [Abstract] [Full Text] [Related]

  • 14. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X, Lu Q, Zhao Y, Ren Z, Ren XW, Qiu QH, Tong Y, Liang M, Hu F, Chen HZ.
    Int J Mol Med; 2005 Dec 01; 16(6):1179-84. PubMed ID: 16273304
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ, Sieg SM, Beckett ML, Schellhammer PF, Ladaga LE, Wright GL.
    Cancer Res; 1982 Aug 01; 42(8):3084-9. PubMed ID: 7046915
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies with fine specificities distinguishing alpha-fetoproteins of hepatoma and yolk sac tumor origin.
    Kitagawa H, Ohkouchi E, Hata J, Tsuchida Y, Fukuda A, Tada T.
    Jpn J Cancer Res; 1986 Oct 01; 77(10):1012-7. PubMed ID: 2430923
    [Abstract] [Full Text] [Related]

  • 17. Binding and endocytosis of a monoclonal antibody to a high molecular weight human milk fat globule membrane-associated antigen by cultured MCF-7 breast carcinoma cells.
    Aboud-Pirak E, Sergent T, Otte-Slachmuylder C, Abarca J, Trouet A, Schneider YJ.
    Cancer Res; 1988 Jun 01; 48(11):3188-96. PubMed ID: 3365702
    [Abstract] [Full Text] [Related]

  • 18. [Epitopic multiple antigen peptide from α-fetoprotein elicit antitumor immune response in vitro and ex vivo].
    Fan ZJ, Zhang SR.
    Zhonghua Yi Xue Za Zhi; 2012 Apr 24; 92(16):1138-42. PubMed ID: 22781777
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP, Grzyb KT, Dressler LG, Mansel RE, Zava DT, Sledge GW, McGuire WL.
    Cancer Res; 1986 Mar 24; 46(3):1306-17. PubMed ID: 3510721
    [Abstract] [Full Text] [Related]

  • 20. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K.
    Cancer Gene Ther; 1998 Mar 24; 5(5):301-6. PubMed ID: 9824049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.